Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 6.40
+0.06 (0.95%)
Aug 7, 2025, 5:29 PM CET
Boule Diagnostics AB Market Cap
Boule Diagnostics AB has a market cap or net worth of 246.20 million as of August 7, 2025. Its market cap has decreased by -36.60% in one year.
Market Cap
246.20M
Enterprise Value
430.90M
Revenue
515.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
Market Cap Chart
Since June 23, 2011, Boule Diagnostics AB's market cap has increased from 162.45M to 246.20M, an increase of 51.56%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 246.20M | -29.40% |
| Dec 30, 2024 | 348.72M | -19.96% |
| Dec 29, 2023 | 435.71M | -25.70% |
| Dec 30, 2022 | 586.38M | -38.11% |
| Dec 30, 2021 | 947.53M | -17.98% |
| Dec 30, 2020 | 1.16B | -12.76% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 92.91B |
| Sectra AB | 67.67B |
| Getinge AB | 52.15B |
| Medicover AB | 40.46B |
| Camurus AB | 38.80B |
| Asker Healthcare Group AB | 38.19B |
| Bonesupport Holding AB | 20.98B |
| AddLife AB | 20.51B |